Literature DB >> 19376193

A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms.

Cyrille B Confavreux1, Robert L Levine, Gerard Karsenty.   

Abstract

Thanks to integrative physiology, new relationships between organs and homeostatic functions have emerged. This approach to physiology based on a whole organism approach has allowed the bone field to make fundamental progress. In the last decade, clinical observations and scientific evidences in vivo have uncovered that fat with leptin controls bone mass through brain including a hypothalamic relay and sympathetic nervous system. The finding that energy metabolism affects bone remodelling suggested that in an endocrine perspective, a feedback loop should exist. Beside its classical functions, bone can now be considered as a true endocrine organ secreting osteocalcin, a hormone pharmacologically active on glucose and fat metabolism. Indeed osteocalcin stimulates insulin secretion and beta-cell proliferation. Simultaneously, osteocalcin acts on adipocytes to induce Adiponectin which secondarily reduce insulin resistance. This cross regulation between bone and energy metabolism offers novel therapeutic targets in type 2 diabetes and osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19376193      PMCID: PMC3667507          DOI: 10.1016/j.mce.2009.04.004

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  62 in total

Review 1.  Conditional control of gene expression in the mouse.

Authors:  M Lewandoski
Journal:  Nat Rev Genet       Date:  2001-10       Impact factor: 53.242

Review 2.  Therapeutic approaches to bone diseases.

Authors:  G A Rodan; T J Martin
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

3.  Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.

Authors:  P Ducy; M Amling; S Takeda; M Priemel; A F Schilling; F T Beil; J Shen; C Vinson; J M Rueger; G Karsenty
Journal:  Cell       Date:  2000-01-21       Impact factor: 41.582

Review 4.  Leptin regulation of neuroendocrine systems.

Authors:  R S Ahima; C B Saper; J S Flier; J K Elmquist
Journal:  Front Neuroendocrinol       Date:  2000-07       Impact factor: 8.606

Review 5.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

6.  Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.

Authors:  Romain Dacquin; Michael Starbuck; Thorsten Schinke; Gérard Karsenty
Journal:  Dev Dyn       Date:  2002-06       Impact factor: 3.780

7.  The circadian rhythm of osteoprotegerin and its association with parathyroid hormone secretion.

Authors:  F Joseph; B Y Chan; B H Durham; A M Ahmad; S Vinjamuri; J A Gallagher; J P Vora; W D Fraser
Journal:  J Clin Endocrinol Metab       Date:  2007-06-05       Impact factor: 5.958

8.  Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice.

Authors:  Tomoaki Morioka; Esra Asilmaz; Jiang Hu; John F Dishinger; Amarnath J Kurpad; Carol F Elias; Hui Li; Joel K Elmquist; Robert T Kennedy; Rohit N Kulkarni
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

9.  Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation.

Authors:  L J Mauro; E A Olmsted; B M Skrobacz; R J Mourey; A R Davis; J E Dixon
Journal:  J Biol Chem       Date:  1994-12-02       Impact factor: 5.157

10.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.

Authors:  T Yamauchi; J Kamon; H Waki; Y Terauchi; N Kubota; K Hara; Y Mori; T Ide; K Murakami; N Tsuboyama-Kasaoka; O Ezaki; Y Akanuma; O Gavrilova; C Vinson; M L Reitman; H Kagechika; K Shudo; M Yoda; Y Nakano; K Tobe; R Nagai; S Kimura; M Tomita; P Froguel; T Kadowaki
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

View more
  88 in total

Review 1.  Type 2 diabetes and bone fractures.

Authors:  Kendall F Moseley
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-04       Impact factor: 3.243

2.  Relationship between serum omentin-1 level and bone mineral density in girls with anorexia nervosa.

Authors:  L-J Guo; T-J Jiang; L Liao; H Liu; H-B He
Journal:  J Endocrinol Invest       Date:  2012-06-18       Impact factor: 4.256

Review 3.  Bone metabolism markers in sports medicine.

Authors:  Giuseppe Banfi; Giovanni Lombardi; Alessandra Colombini; Giuseppe Lippi
Journal:  Sports Med       Date:  2010-08-01       Impact factor: 11.136

Review 4.  Implications of exercise-induced adipo-myokines in bone metabolism.

Authors:  Giovanni Lombardi; Fabian Sanchis-Gomar; Silvia Perego; Veronica Sansoni; Giuseppe Banfi
Journal:  Endocrine       Date:  2015-12-30       Impact factor: 3.633

Review 5.  A four-season molecule: osteocalcin. Updates in its physiological roles.

Authors:  Giovanni Lombardi; Silvia Perego; Livio Luzi; Giuseppe Banfi
Journal:  Endocrine       Date:  2014-08-27       Impact factor: 3.633

Review 6.  Chaperoning osteogenesis: new protein-folding disease paradigms.

Authors:  Elena Makareeva; Nydea A Aviles; Sergey Leikin
Journal:  Trends Cell Biol       Date:  2010-12-21       Impact factor: 20.808

7.  Vitamin D, osteocalcin, and risk for adiposity as comorbidities in middle school children.

Authors:  Claudia Boucher-Berry; Phyllis W Speiser; Dennis E Carey; Steven P Shelov; Siham Accacha; Ilene Fennoy; Robert Rapaport; Yomery Espinal; Michael Rosenbaum
Journal:  J Bone Miner Res       Date:  2012-02       Impact factor: 6.741

Review 8.  WNT signaling in bone homeostasis and disease: from human mutations to treatments.

Authors:  Roland Baron; Michaela Kneissel
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

9.  Prostaglandin E2: from clinical applications to its potential role in bone- muscle crosstalk and myogenic differentiation.

Authors:  Chenglin Mo; Sandra Romero-Suarez; Lynda Bonewald; Mark Johnson; Marco Brotto
Journal:  Recent Pat Biotechnol       Date:  2012-12

Review 10.  Muscle-bone and fat-bone interactions in regulating bone mass: do PTH and PTHrP play any role?

Authors:  Nabanita S Datta
Journal:  Endocrine       Date:  2014-05-07       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.